CLINICAL TRIAL BIOREPOSITORY AND ARCHIVING SOLUTIONS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Name: Clinical Trial Biorepository and Archiving Solutions Market News
Creator: Coherent Market Insights
License: https://www.coherentmarketinsights.com/privacy-policy

Clinical Trial Biorepository and Archiving Solutions Market, By Product (Preclinical Products and Clinical Products), By Phase (Phase I, Phase II, Phase III, Phase IV), By Services (Biorepository Services and Archiving Solution Services), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jul 2024
Code : CMI7134
Pages :140
Formats :
Excel and PDF
Industry : Medical Devices

Key Developments

In April 2024 The Lupus Nexus program was developed by The Lupus Research Alliance (LRA) and Lupus Therapeutics (LT) in partnership with industry partners. To speed up lupus research, this incorporates a novel biorepository, lupus registry, and data exchange platform. The Lupus Landmark research (LLS), five-year longitudinal research involving 3,500 lupus patients, is at the heart of the effort. The Data Repository, Exchange, and Analysis (DREAM) platform will be able to receive biospecimens and a wealth of clinical and patient-reported data from the LLS to aid in ongoing lupus research efforts.
In October 2021, Azenta Life Sciences, a provider of life sciences services including genomics, cryogenic storage, automation, and informatics, and Cleveland Clinic inaugurated a new 22,000-square-foot facility for biospecimen sample management and repository on the Cleveland Clinic’s main campus. This facility aims to significantly enhance Cleveland Clinic's biobanking capabilities and accelerate translational research efforts.